Recently presented data from a preclinical study performed using Inovio Pharmaceuticals��(NYSE: INO) DNA vaccine against the H7N9 strain of avian influenza (bird flu) garnered some interest and buying momentum in INO, although investors seemed even more impressed after the release of the peer-reviewed publication analyzing the data from 2 Phase I trials for Inovio�� PENNVAX-B vaccine, which was delivered using Inovio�� CELLECTRA electroporation device. PENNVAX induced a strong T-cell response in 89% of the patients that had received three doses of the vaccine plus a signaling protein called Interleukin-12, inducing a best-in-class immune system response against HIV.
In light of the data, INO is up 93% in the last month of trading and hit a recent 52-week high of $1.57/share. Although the stock has pulled back, investors who are bullish on the stock now have more detailed Phase I clinical data supporting their position.
Top 10 Defense Stocks For 2016: BNP Paribas SA (BNP)
BNP Paribas SA is a France-based bank group with four core businesses: Retail Banking, Corporate & Investment Banking, Investment Solutions and Other Activities. Retail Banking comprises the French retail banking division, Banca Nazionale del Lavoro in Italy, BeLux Retail Banking, Europe-Mediterranean, all BNP Paribas Group retail banking businesses out of Euro Zone: in the United States, in Asia, in the Mediterranean Basin and Africa, in Turkey, Central and Eastern Europe, personal finance and equipment solutions. The Corporate & Investment Banking business provides to its clients financing, advisory and capital markets services. The Investment Solutions division offers private banking, asset management, securities services, real estate and insurance services. In November 2013, the Company launched 'Hello Bank!', a mobile, digital bank operating in France, Belgium and Germany. Advisors' Opinion:- [By Namitha Jagadeesh]
BNP Paribas SA (BNP), Societe Generale SA (GLE) and Credit Agricole SA (ACA), France�� largest banks by market value, reported second-quarter profit that exceeded analysts��estimates. Paris-based Societe Generale, which said income more than doubled from a year earlier, trades at 10.8 times projected earnings, 64 percent below its 2009 high. Credit Agricole trades at 8.6 times projected profit and BNP Paribas at 10.7 times, according to data compiled by Bloomberg.
Hot Healthcare Equipment Stocks To Buy Right Now: Diamondback Energy Inc (FANG)
Diamondback Energy, Inc., incorporated on December 30, 2011, is an independent oil and natural gas company. The Company is focused on the acquisition, development, exploration and exploitation of unconventional, onshore oil and natural gas reserves in the Permian Basin in West Texas. The Company is the operator of Janey 16H in Upton County with a 3,842 foot lateral in the Wolfcamp B interval. During the year ended December 31, 2012, the Janey 16H had produced a total of 48 thousand barrels of oil and 62 million cubic feet of natural gas. As of December 31, 2012, the Company had drilled 193 gross (176 net) wells, and participated in an additional 18 gross (eight net) non-operated wells, in the Permian Basin. Of these 211 gross wells, 191 were completed as producing wells and 20 were in various stages of completion. In the aggregate, as of December 31, 2012, it held interests in 225 gross (201 net) producing well in the Permian Basin.
The Company�� activities are primarily focused on the Clearfork, Spraberry, Wolfcamp, Cline, Strawn and Atoka formations, which it refers to collectively as the Wolfberry play. The Wolfberry play is characterized by high oil and liquids rich natural gas, multiple vertical and horizontal target horizons, extensive production history, long-lived reserves and high drilling success rates. The Wolfberry play is a modification and extension of the Spraberry play, the majority of which is designated in the Spraberry Trend area field. As of December 31, 2012, its estimated proved oil and natural gas reserves were 40,210 million barrels of oil equivalent based on a reserve report prepared by Ryder Scott Company L.P. (Ryder Scott), its independent reserve engineers. Of these reserves, approximately 29.5% are classified as proved developed producing, (PDP). Proved undeveloped (PUD), reserves included in this estimate are from 306 vertical gross well locations on 40-acre spacing and four gross horizontal well locations. As of December 31, 2012, these proved reserves wer! e approximately 65% oil, 21% natural gas liquids and 14% natural gas.
The Company had have 881 identified potential vertical drilling locations on 40-acre spacing based on its evaluation of applicable geologic and engineering data as of December 31, 2012, and had an additional 1,118 identified potential vertical drilling locations based on 20-acre downspacing. It also has identified 731 potential horizontal drilling locations in multiple horizons on its acreage. The Company�� second horizontal well, Kemmer 4209H in Midland County is a non-operated well in which the Company owns a 47% working interest. In 2012, the Kemmer 4209H produced a total of 41 thousand barrels of oil and 45 million cubic feet of natural gas. In addition to the Janey and Kemmer wells, as of February 28, 2013, the Company had three additional horizontal wells in Midland County and four horizontal wells in Upton County in various stages of development. In Midland County, it drilled the ST25-1H well (83% working interest) with a lateral length of 4,617 feet.
In Upton County, the Company drilled three additional wells, the Neal 8-1H (100% working interest) with a lateral length of 7,652 feet, the Neal 8-2H (100% working interest) with a lateral length of 6,658 feet and the Janey 3H (100% working interest) with a lateral length of 4,629 feet. It completed a 32 stage frac on the Neal 8-1H well in January 2013. As of February 26, 2013, flowback operations were underway and for the last seven days the well averaged 806 barrel of oil equivalent per day with a peak rate of 871 barrel of oil equivalent per day with an 85% oil component.
Advisors' Opinion:- [By Jake L'Ecuyer]
Diamondback Energy (NASDAQ: FANG) shares were also up, gaining 5.73 percent to $69.39 after the company reported a 30% growth in Q1 production.
Equities Trading DOWN
Shares of The Gap (NYSE: GPS) were down 2.53 percent to $38.29 after the company reported a 6% decline in its same-store sales in March, versus analysts' expectations for a 4.7% fall. - [By Robert Rapier]
Viper Energy Partners�(NASDAQ: VNOM), a spinoff from�Diamondback Energy�(NASDAQ: FANG). Viper owns mineral rights on 14,804 acres in the Permian Basin in West Texas, and became the first US-listed partnership structured on the basis of royalty payments
Hot Healthcare Equipment Stocks To Buy Right Now: Mead Johnson Nutrition Company (MJN)
Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children?s nutritional products, and other nutritional products in Asia, Europe, Latin America, and North America. Its infant formula products include formulas for routine feeding; solutions formulas for mild intolerance and specialty formula products, including formulas for severe intolerance; formulas for premature and low birth weight infants; and medical nutrition products. The company also offers products for infants with milk protein allergy, gas/fussiness, lactose intolerance, anti-regurgitation, severe protein sensitivity, multiple food allergies, fat malabsorption, and premature infants, as well as soy formula. Its children?s nutrition products comprise nutritious powdered milk for picky eaters, nutritious powdered milk, and nutritious milk modifier. The company also offers a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nurs ing mothers. Mead Johnson Nutrition Company markets its products under the Enfamil, Enfalac, Enfapro, Nutramigen, Pregestimil, Enfacare, Enfagrow, EnfaSchool, Enfakid, Sustagen KID, Lactum, Alacta, ChocoMilk, Cal-C-Tose, Expecta LIPIL, and EnfaMama names. It sells its products to retail channels, including mass merchandisers, club stores, grocery stores, drug stores, and convenience stores. The company was founded in 1905 and is headquartered in Glenview, Illinois. Mead Johnson Nutrition Company (NYSE: MJN), formerly a subsidiary of Bristol-Myers Squibb Co., completed its initial public offering in February 2009.
Advisors' Opinion:- [By Monica Gerson]
Mead Johnson Nutrition Company (NYSE: MJN) is estimated to report its Q3 earnings at $0.80 per share on revenue of $998.82 million.
KBR (NYSE: KBR) is expected to post its Q3 earnings at $0.70 per share on revenue of $1.99 billion.
Hot Healthcare Equipment Stocks To Buy Right Now: EMCORE Corporation(EMKR)
EMCORE Corporation, together with its subsidiaries, provides compound semiconductor-based products for the broadband, fiber optics, satellite, and solar power markets. The company operates in two segments, Fiber Optics and Photovoltaics. The Fiber Optics segment offers broadband products, including cable television, fiber-to-the-premises, satellite communication, video transport, and defense and homeland security products; and digital products comprising telecom optical, enterprise, laser/photodetector component, parallel optical transceiver and cable, and fiber channel transceiver products. This segment?s products enable information that is encoded on light signals to be transmitted, routed, and received in communication systems and networks. The Photovoltaics segment provides gallium arsenide (GaAs) multi-junction solar cells, covered interconnected cells, and solar panels for satellite applications; and concentrating photovoltaic (CPV) power systems for commercial and utility scale solar applications, as well as GaAs solar cells and integrated CPV components for use in other solar power concentrator systems. The company markets its products through its direct sales force, external sales representatives and distributors, and application engineers worldwide. EMCORE Corporation was founded in 1984 and is headquartered in Albuquerque, New Mexico.
Advisors' Opinion:- [By CRWE]
EMCORE Corporation (Nasdaq:EMKR), a leading provider of compound semiconductor-based components and subsystems for the fiber optic and solar power markets, reported that it is ramping production and shipping the Opticomm-EMCORE NEXTGEN OTP-1DVI2A1SU insert cards for the Optiva platform.
- [By Roberto Pedone]
EMCORE (EMKR), together with its subsidiaries, provides compound semiconductor-based products for the broadband, fiber optics, satellite, and solar power markets. This stock closed up 1% to $4.09 in Tuesday's trading session.
Tuesday's Range: $4.00-$4.14
52-Week Range: $3.50-$5.62
Tuesday's Volume: 187,000
Three-Month Average Volume: 103,744From a technical perspective, EMKR trended modestly higher here back above its 50-day moving average of $4.03 with above-average volume. This stock has been making higher lows over the last three months each time it has pulled back, which is a bullish technical sign. This spike to the upside on Tuesday is starting to push shares of EMKR within range of triggering a big breakout trade. That trade will hit if EMRK manages to take out some key near-term overhead resistance levels at $4.16 to $4.20 and then above $4.22 with high volume.
Traders should now look for long-biased trades in EMKR as long as it's trending above some key near-term support levels at $3.90 to $3.86 or above more support at $3.78 and then once it sustains a move or close above those breakout levels with volume that hits near or above 103,744 shares. If that breakout gets underway soon, then EMKR will set up to re-test or possibly take out its next major overhead resistance levels at $4.53 to its 200-day moving average of $4.65, or even $5 to $5.30.
Hot Healthcare Equipment Stocks To Buy Right Now: Cornerstone Strategic Value Fund Inc (CLM)
Cornerstone Strategic Value Fund, Inc. (the Fund), incorporated on May 1, 1987, is a closed-end, diversified management investment company. The Fund invests in equity securities of companies listed in the United States. Cornerstone Strategic Value Fund, Inc. invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, consumer staples, energy, utilities, telecommunication services, materials and other sectors.
As of December 31, 2005, the Fund's top 10 holdings were General Electric Co., Exxon Mobil Corp., Microsoft Corp., Citigroup Inc., Procter & Gamble Co. (The), EMC Corp., Bank of America Corp., American International Group, Inc., Johnson & Johnson and Pfizer Inc. Cornerstone Strategic Value Fund, Inc.'s investment manager is Cornerstone Advisors, Inc.
Advisors' Opinion:- [By Dividends4Life]
According to a Gabelli Funds report, managed distribution policies offer several advantages, including:1. Lower difference between the fund�� market price and its NAV per share.2. Provides support during periods when the stock market is in a decline.3. Provides a measurable performance target for the investment adviser.Below are several high-yield funds from CEFA that have a managed distribution policy (yields as of December 16):Aberdeen Australia Eqty (IAF)- Distribution Yield: 10.4%- Income Yield: 3.46%Bexil Advisers LLC� (DNI)- Distribution Yield: 11.1%- Income Yield: 3.56%BlackRock En Capital&Inc (CII)- Distribution Yield: 8.78%- Income Yield: 2.34%Cornerstone Strat Value (CLM)- Distribution Yield: 18.77%- Income Yield: 1.83%Cornerstone Total Return (CRF)- Distribution Yield: 19.10%- Income Yield: 0.85%Delaware Inv Div & Inc (DDF)- Distribution Yield: 6.70%- Income Yield: 5.26%Gabelli Equity Trust (GAB)- Distribution Yield: 7.58%- Income Yield: 1.54%Gabelli Utility Trust (GUT)- Distribution Yield: 9.45%- Income Yield: 2.84%MFS Special Value Trust (MFV)- Distribution Yield: 9.60%- Income Yield: 5.73%Nuveen Tx-Adv TR Strat (JTA)- Distribution Yield: 6.70%- Income Yield: 3.12%TCW Strategic Income (TSI)- Distribution Yield: 10.54%- Income Yield: 7.88%Zweig Total Return (ZTR)- Distribution Yield: 7.27%- Income Yield: 1.95%As noted in the Gabelli report, a managed distribution policy may create confusion regarding the true current yield since the reported yield includes the return of capital portion. You can see the disparity above between the income yield and the distribution (reported) yield.If you are looking for a sustainable and growing dividend, you may want to consider some blue-chip dividend stocks such as these with a Free Cash Flow Payout less than 50%, 50+ years of consecutive dividend increases and a 2%+ yield:3M Co. (MMM) is a diversified global company provides enhanced product functionality in electronics, health care, industrial, consumer
Hot Healthcare Equipment Stocks To Buy Right Now: The Advisory Board Company(ABCO)
The Advisory Board Company, together with its subsidiaries, engages in the provision of best practices research and analysis, business intelligence and software tools, and management and advisory services primarily in the United States. The company offers various programs and services, including best practices research services that focus on identifying best-demonstrated management practices, critiquing widely-followed but ineffective practices, and analyzing emerging trends in the health care and education industries; business intelligence and software tools, which allow members to pair their own operational data with the best practices insights; and management and advisory services programs for assisting member institutions to adopt and implement best practices to enhance performance. As of June 30, 2011, it provided 51 distinct membership programs to hospitals, health systems, colleges, universities, pharmaceutical and biotech companies, health care insurers, medical de vice and supply companies, and other educational institutions. The company was founded in 1979 and is headquartered in Washington, District of Columbia.
Advisors' Opinion:- [By Jeremy Bowman]
What: Shares of The Advisory Board Company (NASDAQ: ABCO ) were up as much as 12% today, after the consulting firm beat top and bottom-line estimates in its quarterly report.
- [By Seth Jayson]
Advisory Board (Nasdaq: ABCO ) is expected to report Q4 earnings on May 9. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Advisory Board's revenues will grow 17.4% and EPS will grow 21.7%.
No comments:
Post a Comment